4//SEC Filing
Roberts Calvin W. 4
Accession 0001410939-23-000087
CIK 0001410939other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 5:53 PM ET
Size
6.2 KB
Accession
0001410939-23-000087
Insider Transaction Report
Form 4
IVERIC bio, Inc.ISEE
Roberts Calvin W.
Director
Transactions
- Award
Restricted Stock Units
2023-05-17+7,500→ 7,500 total→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the units.
- [F2]Subject to the Reporting Person providing continued services to the Registrant and other terms and conditions under the Registrant's 2023 Stock Incentive Plan, the award of restricted stock units will vest in full on the earlier of one business day prior to the Registrant's 2024 annual meeting of stockholders or the first anniversary of the grant date. Any unvested shares subject to the award of restricted stock units will be accelerated in full upon the occurrence of a change in control event (as defined in the Registrant's 2023 Stock Incentive Plan). For purposes of this report on Form 4, a change in control event includes the closing of the transaction contemplated by the Agreement and Plan of Merger, dated April 28, 2023, between the Registrant, Astellas US Holding, Inc., Berry Merger Sub, Inc. and solely as provided by Section 8.10(b) of such agreement, Astellas Pharma Inc.
Documents
Issuer
IVERIC bio, Inc.
CIK 0001410939
Entity typeother
Related Parties
1- filerCIK 0001489535
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 5:53 PM ET
- Size
- 6.2 KB